Publication Name	World Journal of Gastrointestinal Endoscopy
Manuscript ID	106083
Country	United Arab Emirates

Received	2025-02-17 14:10
Peer-Review Started	2025-02-18 05:40
To Make the First Decision
Return for Revision	2025-03-20 09:08
Revised	2025-03-23 16:39
Second Decision	2025-04-03 02:38
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2025-04-03 08:12
Articles in Press	2025-04-03 08:12
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2025-04-09 04:20
Publish the Manuscript Online	2025-04-14 07:02

ISSN	1948-5190 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Letter to the Editor
Article Title	Assessing endoscopic remission in small bowel Crohn's disease: Are markers enough?
Manuscript Source	Invited Manuscript
All Author List	Iyad A Issa and Taly Issa
Funding Agency and Grant Number
Corresponding Author	Iyad A Issa, Department of Gastroenterology and Hepatology, Harley Street Medical Center, Marina Village, Villa No. A21, Abu Dhabi 41475, United Arab Emirates. iyadissa71@gmail.com
Key Words	Biomarker; C-reactive protein; Crohn’s disease; Diagnosis; Fecal calprotectin; Inflammatory bowel disease; Leucine-rich 𝛼2 glycoprotein
Core Tip	Small bowel Crohn’s disease can be challenging to monitor during treatment. Balloon endoscopy is an invasive procedure, and capsule enteroscopy is costly. The identification of the optimal biomarker remains an ongoing research area. Leucine-rich α2 glycoprotein presents a promising solution, which is discussed in the trial conducted by Ohno et al.
Publish Date	2025-04-14 07:02
Citation	<p>Issa IA, Issa T. Assessing endoscopic remission in small bowel Crohn's disease: Are markers enough? <i>World J Gastrointest Endosc</i> 2025; 17(4): 106083</p>
URL	https://www.wjgnet.com/1948-5190/full/v17/i4/106083.htm
DOI	https://dx.doi.org/10.4253/wjge.v17.i4.106083

Full Article (PDF)	WJGE-17-106083-with-cover.pdf
Manuscript File	106083_Auto_Edited_054313.docx
Answering Reviewers	106083-answering-reviewers.pdf
Audio Core Tip	106083-audio.mp3
Conflict-of-Interest Disclosure Form	106083-conflict-of-interest-statement.pdf
Copyright License Agreement	106083-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	106083-non-native-speakers.pdf
Peer-review Report	106083-peer-reviews.pdf
Scientific Misconduct Check	106083-scientific-misconduct-check.png
Scientific Editor Work List	106083-scientific-editor-work-list.pdf
CrossCheck Report	106083-crosscheck-report.pdf